High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin

被引:162
作者
Ma, Zengshuan [1 ]
Shayeganpour, Anooshirvan [1 ]
Brocks, Dion R. [1 ]
Lavasanifar, Afsaneh [1 ]
Samuel, John [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
关键词
curcumin; HPLC; polymeric micelle; pharmacokinetics;
D O I
10.1002/bmc.795
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, rapid and reliable high-performance liquid chromatographic (HPLC) method was developed and validated for the determination of curcumin in rat plasma. Plasma was precipitated with acetonitrile after addition of the internal standard (IS), 4-hydroxybenzophenone. Separation was achieved on a Waters mu Bondapak (TM) C-18 column (3.9 x 300mm, 5 4 mu m) using acetonitrile (55%) and citric buffer, pH 3.0 (45%) as the mobile phase (flow rate = 1.0 mL/min). The UV detection wavelength was 300 and 428 nm for IS and curcumin, respectively. The extraction efficiencies were 97.08, 95.69 and 94.90% for 50, 200 and 1000 ng/mL of curcumin in rat plasma, respectively. The calibration curve was linear over the range 0.02-1 mu g/mL with a correlation coefficient of r(2) > 0.999. The intra- and inter-day coefficients of variation were less than 13%, and mean intra- and inter-day errors were less than +/- 6% at 50, 200 and 1000 ng/mL of curcumin. This assay was successfully applied to the pharmacokinetic studies of both solubilized curcumin and its polymeric micellar formulation in rats. It was found that polymeric micelles increased the half-life of curcumin 162-fold that of solubilized curcumin and increased the volume of distribution (Vd(ss)) by 70-fold. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 24 条
  • [1] Micelles of methoxy poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization and controlled delivery of Cyclosporine A
    Aliabadi, HM
    Mahmud, A
    Sharifabadi, AD
    Lavasanifar, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 2005, 104 (02) : 301 - 311
  • [2] Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution
    Aliabadi, HM
    Brocks, DR
    Lavasanifar, A
    [J]. BIOMATERIALS, 2005, 26 (35) : 7251 - 7259
  • [3] Atsumi T, 2005, ANTICANCER RES, V25, P4029
  • [4] Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase
    Belakavadi, M
    Salimath, BP
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 273 (1-2) : 57 - 67
  • [5] Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation
    Brocks, DR
    Betageri, GV
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (08) : 1049 - 1053
  • [6] Cheng AL, 2001, ANTICANCER RES, V21, P2895
  • [7] PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS
    DAVIES, B
    MORRIS, T
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (07) : 1093 - 1095
  • [8] Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation
    Gelderblom, H
    Verweij, J
    Nooter, K
    Sparreboom, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) : 1590 - 1598
  • [9] Molecular mechanisms of anti-angiogenic effect of curcumin
    Gururaj, AE
    Belakavadi, M
    Venkatesh, DA
    Marmé, D
    Salimath, BP
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 297 (04) : 934 - 942
  • [10] NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
    Hamaguchi, T
    Matsumura, Y
    Suzuki, M
    Shimizu, K
    Goda, R
    Nakamura, I
    Nakatomi, I
    Yokoyama, M
    Kataoka, K
    Kakizoe, T
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (07) : 1240 - 1246